|
| 37541199 | Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer. | Cell | 2023 |
| 36259971 | Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety. | Cancer Discov | 2023 |
| 37730181 | Clinical Proteomics for Solid Organ Tissues. | | 2023 |
| 37643636 | Hormone Receptor-Positive Breast Cancer Sensitive to Pembrolizumab: Evidence of the Pathogenicity of the MLH1 Variant 1835del3. | | 2023 |
| 37478973 | Monitoring Both Extended and Tryptic Forms of Stable Isotope-Labeled Standard Peptides Provides an Internal Quality Control of Proteolytic Digestion in Targeted Mass Spectrometry-Based Assays. | | 2023 |
| 36912284 | Fanconi anemia-isogenic head and neck cancer cell line pairs: A basic and translational science resource. | Int J Cancer | 2023 |
| 37273420 | Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia. | | 2023 |
| 37205196 | A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials. | Front Oncol | 2023 |
| 36301140 | Preserving the Phosphoproteome of Clinical Biopsies Using a Quick-Freeze Collection Device. | Biopreserv Biobank | 2022 |
| 35767427 | Internal Standard Triggered-Parallel Reaction Monitoring Mass Spectrometry Enables Multiplexed Quantification of Candidate Biomarkers in Plasma. | Anal Chem | 2022 |
| 34359745 | Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition. | Cancers (Basel) | 2021 |
| 33568520 | Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types. | Science Translational Medicine | 2021 |
| 34136904 | Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues. | Clin Chem | 2021 |
| 34858420 | Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens. | Front Immunol | 2021 |
| 34671754 | Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling. | Cell Rep Methods | 2021 |
| 35028612 | Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer. | Cell Rep Med | 2021 |
| 34429382 | Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function. | Sci Signal | 2021 |
| 33106847 | Quantification of Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Protein Expression in Bone Biopsies by Targeted Mass Spectrometry without Acid Decalcification. | Clinical Chemistry | 2020 |
| 32296420 | Multiplexed Proteomic Analysis for Diagnosis and Screening of Five Primary Immunodeficiency Disorders From Dried Blood Spots. | Frontiers in Immunology | 2020 |
| 32575471 | Identification of a Blood-Based Protein Biomarker Panel for Lung Cancer Detection. | Cancers (Basel) | 2020 |
| 31467290 | A dataset describing a suite of novel antibody reagents for the RAS signaling network. | Sci Data | 2019 |
| 30487530 | Clinical potential of mass spectrometry-based proteogenomics. | Nat Rev Clin Oncol | 2019 |
| 29605812 | Targeted mass spectrometry enables robust quantification of FANCD2 mono-ubiquitination in response to DNA damage. | DNA Repair (Amst) | 2018 |
| 30385821 | pRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry. | Br J Cancer | 2018 |
| 30131370 | Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function. | Sci Signal | 2018 |
| 30564228 | Rapid Multiplexed Proteomic Screening for Primary Immunodeficiency Disorders From Dried Blood Spots. | Frontiers in Immunology | 2018 |
| 29474155 | A Multiplexed Mass Spectrometry-Based Assay for Robust Quantification of Phosphosignaling in Response to DNA Damage. | Radiat Res | 2018 |
| 27935710 | Quantification of ATP7B Protein in Dried Blood Spots by Peptide Immuno-SRM as a Potential Screen for Wilson's Disease. | Journal of Proteome Research | 2017 |
| 28477121 | Peptide Immunoaffinity Enrichment with Targeted Mass Spectrometry: Application to Quantification of ATM Kinase Phospho-Signaling. | Methods in Molecular Biology | 2017 |
| 27727212 | Quantifying the human proteome. | Nature Biotechnology | 2016 |
| 27094115 | Commercially available antibodies can be applied in quantitative multiplexed peptide immunoaffinity enrichment targeted mass spectrometry assays. | Proteomics | 2016 |
| 26867747 | Using the CPTAC Assay Portal to Identify and Implement Highly Characterized Targeted Proteomics Assays. | Methods Mol Biol | 2016 |
| 26719571 | Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays. | Clin Chem | 2016 |
| 27462933 | Optimized Protocol for Quantitative Multiple Reaction Monitoring-Based Proteomic Analysis of Formalin-Fixed, Paraffin-Embedded Tissues. | Journal of Proteome Research | 2016 |
| 26621847 | Immobilized Metal Affinity Chromatography Coupled to Multiple Reaction Monitoring Enables Reproducible Quantification of Phospho-signaling. | Mol Cell Proteomics | 2016 |
| 25987412 | Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry Enables Multiplex, Quantitative Pharmacodynamic Studies of Phospho-Signaling. | Mol Cell Proteomics | 2015 |
| 25693799 | Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma. | Mol Cell Proteomics | 2015 |
| 25512614 | Anti-peptide monoclonal antibodies generated for immuno-multiple reaction monitoring-mass spectrometry assays have a high probability of supporting Western blot and ELISA. | Molecular and Cellular Proteomics | 2015 |
| 26302155 | Antibody-Coupled Magnetic Beads Can Be Reused in Immuno-MRM Assays To Reduce Cost and Extend Antibody Supply. | Journal of Proteome Research | 2015 |
| 26121405 | Assessment of a method to characterize antibody selectivity and specificity for use in immunoprecipitation. | Nat Methods | 2015 |
| 25102069 | Panorama: a targeted proteomics knowledge base. | J Proteome Res | 2014 |
| 24317253 | Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins. | Nat Methods | 2014 |
| 24568200 | High-affinity recombinant antibody fragments (Fabs) can be applied in peptide enrichment immuno-MRM assays. | Journal of Proteome Research | 2014 |
| 24972168 | CPTAC Assay Portal: a repository of targeted proteomic assays. | Nat Methods | 2014 |
| 22199228 | Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma. | Mol Cell Proteomics | 2012 |
| 22577026 | Multiplexed quantification of estrogen receptor and HER2/Neu in tissue and cell lysates by peptide immunoaffinity enrichment mass spectrometry. | Proteomics | 2012 |
| 22203691 | Sequential multiplexed analyte quantification using peptide immunoaffinity enrichment coupled to mass spectrometry. | Mol Cell Proteomics | 2012 |
| 21685906 | A targeted proteomics-based pipeline for verification of biomarkers in plasma. | Nat Biotechnol | 2011 |
| 21245105 | Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry. | Mol Cell Proteomics | 2011 |
| 21448875 | Proteome and transcriptome profiles of a Her2/Neu-driven mouse model of breast cancer. | Proteomics Clin Appl | 2011 |